• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
YU Jiankang,ZHOU Liang,GONG Yinhua,BIAN Jinlei.Design, synthesis and biological evaluation of novel indoleamine 2,3-dioxygenase 1 inhibitors[J].Journal Of Pharmaceutical Research,2022,41(5):281-286,311[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2241times   Download 2605次 QR Code for this article
Scan with your phone!
新型吲哚胺-2,3-双加氧酶1抑制剂的设计及生物活性研究
郁件康1,周良1,龚银华1,卞金磊2
Font:Larger+|Default|Smaller-
(1.苏州大学附属第一医院,江苏 苏州 215006;2.中国药科大学,江苏 南京 211198)
摘要:
目的 吲哚胺2,3-双加氧酶1(Indoleamine-2,3-dioxygenase 1,IDO1)催化色氨酸的氧化裂解,是色氨酸-犬尿氨酸途径中的关键限速步骤。在肿瘤组织中,肿瘤细胞高表达吲哚胺2,3-双加氧酶1,因此设计其小分子抑制剂有望成为有效的肿瘤免疫治疗药物。方法 本研究在前期高通量筛选发现的先导化合物LVS-19的基础上,通过分子对接模型,设计合成新型吲哚胺-2,3-双加氧酶1抑制剂。结果 设计并合成5个衍生物。其中最优化合物6e测得的IC50值为2.61 μmol·L-1,相较于苗头化合物活性提高约3倍的。结论 本研究能为吲哚胺2,3-双加氧酶1抑制剂的结构修饰与改造提供理论依据。
关键词:  吲哚胺-2,3-双加氧酶1  吲哚胺-2,3-双加氧酶1抑制剂  免疫逃逸  设计及与活性研究
DOI:10.13506/j.cnki.jpr.2022.05.001
基金项目:国家自然科学基金青年基金(No.81703347)
Publication Date:May 25, 2022
Design, synthesis and biological evaluation of novel indoleamine 2,3-dioxygenase 1 inhibitors
YU Jiankang1,ZHOU Liang1,GONG Yinhua1,BIAN Jinlei2
(1.The First Affiliated Hospital of Soochow University,Suzhou 215006,China; 2.China Pharmaceutical University, Nanjing 211198,China)
Abstract:
Objective Indoleamine-2,3-dioxygenase 1 (IDO1) catalyzes the oxidative cleavage of tryptophan, which is the first and rate-limiting step in the kynurenine pathway of tryptophan catabolism in mammalian cells. IDO1 is widely expressed in tumor cells, its inhibitors would be a potential cancer immunotherapy drug.Methods With the aim of discovering novel IDO1 inhibitors, a series of novel compounds were designed and synthesized based on our previous reported lead compound LVS-019. Results 5 derivatives were designed and synthesized. Among them, the IC50 value measured by the optimized compound 6E was 2.61 μmol·L-1, which was about 3 times compared to the active activity of the signs. Conclusion These synthetic cyano-based IDO1 inhibitors were expected to provide a theoretical basis for the structural modification of IDO1 inhibitors.
Key words:  Indoleamine-2,3-dioxygenase 1  IDO1 inhibitors  Immune escape  Design and biological evaluation
Today's Visits:485    Total Visits:2383197
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.